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Purificación Muñoz‡, Silvia Mora§, Lidia Sevilla§, Perla Kaliman¶, Eva Tomàs, Anna Gumà,
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Caveolin is believed to play an important role in sort-
ing processes, vesicular trafficking, transmembrane sig-
naling, and molecular transport across membranes. In
this study we have evaluated the expression and distri-
bution of caveolin in skeletal muscle and its interaction
with GLUT4 glucose carriers. Caveolin was expressed to
substantial levels in muscle and its expression was reg-
ulated in muscle; aging and high fat diet enhanced
caveolin expression in skeletal muscle and inversely,
myogenesis down-regulated caveolin in L6E9 cells.
Under fasting conditions, most of caveolin was found
in intracellular membranes and the caveolin present in
the cell surface was found in both sarcolemma and T-
tubules. Insulin administration led to a redistribution of
caveolin from intracellular high density membrane frac-
tions to intracellular lighter density fractions and to the
cell surface; this pattern of insulin-induced redistribu-
tion was different to what was shown by GLUT4. These
results suggests that caveolin is a component of an in-
sulin-regulated machinery of vesicular transport in
muscle.
Quantitative immunoisolation of GLUT4 vesicles ob-
tained from different intracellular GLUT4 populations
revealed the absence of caveolin which substantiates
the lack of colocalization of intracellular GLUT4 and
caveolin. This indicates that caveolin is not involved in
intracellular GLUT4 trafficking in skeletal muscle.
Insulin stimulates glucose transport in skeletal muscle by a
process that is characterized by an enhancement of Vmax values
(1–4). In parallel, insulin causes the recruitment of GLUT4,
the main glucose carrier expressed in skeletal muscle, from an
intracellular compartment to selective domains of sarcolemma
and to T-tubules (5–11). Insulin is not the only effector that
causes redistribution of GLUT4 in skeletal muscle; acute exer-
cise has been demonstrated to cause recruitment of GLUT4 to
the cell surface (12–14). There is not yet direct evidence on
whether exercise recruits GLUT4 to similar cell surface do-
mains and by translocation of similar intracellular GLUT4
compartments in skeletal muscle (12–14).
Important for the understanding of GLUT4 translocation is
the knowledge of the proteins that colocalize with GLUT4 in
the same compartment. A lack of colocalization of GLUT4 and
TGN38 protein both in 3T3 adipocytes (15) and in rat skeletal
muscle (11) has been substantiated, which indicates that the
trans Golgi network is not a major site of the intracellular
GLUT4 pool in adipocytes and in the muscle fiber. Recent
studies have identified some of the proteins that colocalize in
GLUT4-containing vesicles from rat adipocytes and skeletal
muscle. Among the proteins that colocalize with GLUT4 in
intracellular vesicles, the presence of phosphatidylinositol 4-ki-
nase (16), VAMPs (17), SCAMPs/GTV3 (18, 19), gp160 (20–22),
and some low molecular GTP-binding proteins including rab4
(23, 24) have been reported.
Caveolin is a principal component of the coat component of
caveolae (25) and a major phosphoprotein in v-Src-transformed
cells (26). Caveolin is believed to play an important role in
sorting processes, transmembrane signaling and molecular
transport across membranes (27). The relevance of caveolin to
GLUT4 traffic has been recently investigated in 3T3-L1 and rat
adipocytes (28, 29). Scherer et al. (28) have suggested that
caveolae may play an important role in the vesicular transport
of GLUT4 in 3T3-L1 adipocytes. In contrast, Kandror et al. (29)
have concluded that caveolin has no direct structural relation
to the organization of the intracellular glucose transporting
machinery in isolated rat adipocytes. Here, we have studied the
expression and distribution of caveolin in skeletal muscle, the
regulation by insulin of caveolin distribution, and the possible
role of caveolin on GLUT4 traffic.
EXPERIMENTAL PROCEDURES
Materials—125I-Labeled protein A and 125I-labeled sheep anti-mouse
antibody were purchased from ICN. 125I-labeled goat anti-mouse anti-
body and enhanced chemiluminescence system (ECL) were from Amer-
sham Corp. Immobilon poly(vinylidene) fluoride was obtained from
Millipore. All electrophoresis reagents and molecular weight markers
were obtained from Bio-Rad. g-Globulin, wheat germ agglutinin, goat-
anti mouse IgG and goat anti-mouse IgM coupled to agarose, and most
commonly used chemicals were from Sigma.
Antibodies—Both monoclonal (1F8) and polyclonal (OSCRX) antibod-
ies specific for GLUT4 were used in these studies. Monoclonal antibody
1F8 (30) was used for immunoisolation assays. Anti-GLUT4 (OSCRX)
from rabbit was produced after immunization with a peptide corre-
sponding to the final 15 amino acids of the carboxyl terminus (31). A
rabbit polyclonal antibody against rat b1-integrin was kindly given by
Dr. Carles Enrich (University of Barcelona) (32). A rabbit polyclonal
antibody against the a2 component of Ca
21 channels (dihydropyridine
receptors) (33) was obtained from Dr. Michel Lazdunski (Centre de
Biochimie, Centre National de la Recherche Scientifique, Sophia Anti-
polis). Monoclonal antibody A-52 against Ca21-ATPase (34) was kindly
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donated by Dr. David H. MacLennan (University of Toronto). Mono-
clonal antibody against caveolin was obtained from Transduction Lab-
oratories. Monoclonal antibody SY38 against synaptophysin was ob-
tained from Boehringer Mannheim.
Animals and Tissue Sampling—For experiments dealing with the
regulation of caveolin expression in skeletal muscle, 3- and 12-month-
old male Wistar rats subjected to either regular chow diet (23% pro-
teins, 5% fat, 50% carbohydrates, 4% cellulose, 6% minerals, w/w) or
high fat diet for the last 6 months (13% proteins, 40% fat, 12% carbo-
hydrates, 2% cellulose, 5% minerals, w/w) were used. For studies on the
subcellular distribution of caveolin, male Wistar rats weighing between
250 and 300 g fed with Purina Laboratory Chow ad libitum were used.
Animals were housed in animal quarters and maintained at 22 °C with
a 12-h light, 12-h dark cycle. After an overnight fast, rats were anes-
thetized with sodium pentobarbital, and some were injected with insu-
lin (intravenously, 10 units/kg of body weight) and D-glucose (intra-
peritoneally, 1 g/kg of body weight) 30 min prior to tissue removal. At
that time, white portions of gastrocnemius and quadriceps muscles
were rapidly excised and immediately processed.
Cell Culture—Rat skeletal muscle cell line L6E9 was grown in mono-
layer culture in a-minimal essential medium containing 10% (v/v) fetal
bovine serum and 1% (v/v) antibiotic (10,000 units/ml penicillin G and
10 mg/ml streptomycin). To obtain myotubes from both L6E9 myo-
blasts, subconfluents monolayers were maintained in 2% fetal bovine
serum. After 4 days under these conditions they spontaneously differ-
entiated into multinucleated myotubes.
Preparation of Total Membrane Fractions from Muscle—Total mem-
brane fractions were obtained as described previously (35). In short,
muscle was homogenized with a Polytron (setting 6, 2 3 30 s) in 10
volumes of ice-cold buffer containing 25 mM Hepes, 250 mM sucrose, 4
mM EDTA, 1 trypsin inhibitory unit/ml of aprotinin, 25 mM benzami-
dine, 0.2 mM phenylmethylsulfonyl fluoride, 1 mM leupeptin, and 1 mM
pepstatin, pH 7.4. The homogenates were centrifuged at 15,000 3 g for
20 min at 4 °C. The supernatants were adjusted to 0.8 M KCl, incubated
at 4 °C for 30 min, and then centrifuged for 90 min at 200,000 3 g at
4 °C to obtain the total membrane fractions. The membrane pellets
were resuspended in homogenization buffer and repeatedly passed
through a 25-gauge needle before storage at 220 °C. Total L6E9 mem-
branes were prepared as follows. The cells were gently scraped in
homogenization buffer (250 mM sucrose, 2 mM EGTA, 5 mM NaN3, 20
mM Hepes, pH 7.4, containing 1 mM leupeptin, 1 mM pepstatin, and 0.5
mM phenylmethylsulfonyl fluoride) followed by 20 strokes with a
Dounce type A homogenizer. The cell homogenate was centrifuged at
760 3 g for 5 min to remove nuclei, mitochondria, and unlysed cells,
followed by centrifugation at 190,000 3 g for 60 min to obtain the total
cell membranes. The pellets were resuspended in homogenization
buffer. Proteins were measured by the method of Bradford (36) using
g-globulin as a standard.
Subcellular Fractionation of Rat Skeletal Muscle Membranes—The
different cell surface and intracellular membrane fractions were iso-
lated as reported elsewhere (37). Approximately 12 g of rat skeletal
muscle were excised, weighed, minced, and initially homogenized with
a Polytron at a low speed (setting 4, 2 3 5 s) in buffer A (20 mM
Tris-HCl, 0.25 M sucrose, 1 mM EDTA, 1 mM pepstatin, 1 mM leupeptin,
pH 7.4; 1 g/4 ml). The homogenate was centrifuged for 20 min at 12,000
3 g (9,000 rpm in SA-600 Sorvall rotor). The supernatant was collected
and kept on ice. The pellet was resuspended in buffer A and centrifuged
again for 20 min at 12,000 3 g. The two supernatants were pooled and
are referred to as the F1 fraction. The pellet was resuspended in buffer
A and subjected to a high speed homogenization (Polytron at setting 6,
2 3 30 s). The homogenate was centrifuged for 20 min at 12,000 3 g,
and the supernatant was collected and referred to as F2. F1 and F2
fractions were incubated with 0.6 M KCl for 1 h at 4 °C and then pelleted
for 1 h at 150,000 3 g in a T-647.5 Sorvall rotor. The pellets from
KCl-washed F1 and F2 fractions were then subjected to calcium loading
in order to increase the density of sarcoplasmic reticulum vesicles (38).
To this end, pellets were resuspended in buffer B (50 mM potassium
phosphate, 5 mMMgCl2, 150 mM KCl, pH 7.5) at a protein concentration
of 2 mg/ml. Calcium loading was initiated by addition of 0.3 mM CaCl2
and 2 mM ATP. After incubation for 20 min at room temperature, F1
and F2 fractions were kept on ice and centrifuged for 60 min at 150,000
3 g. F1 and F2 pellets were resuspended in buffer C (20 mM Tris-HCl,
50 mM sodium pyrophosphate, 0.3 M KCl, 0.25 M sucrose, pH 7.2) and
layered on top of a discontinuous density gradient consisting of 3 ml of
35%, 2 ml 29%, 2 ml 26%, and 2 ml of 23% (w/v) sucrose. After centrif-
ugation for 12 h at 77,000 3 g (25,000 rpm in a TH-641 Sorvall rotor),
four protein fractions were separated from F1 and F2 fractions: fraction
23 on top of the 23% layer; fraction 26 from the interphase 23–26%;
fraction 29 from the interphase 26–29%; fraction 35 from the inter-
phase 29–35%. In some experiments, the pellet resulting from this
centrifugation was also collected (pellet F1 and pellet F2). All the
fractions were collected, diluted with 20 mM Tris-HCl, pH 7.4 and
centrifuged for 60 min at 150,000 3 g. Pellets were resuspended in 30
mM Hepes, 0.25 M sucrose, pH 7.4. Proteins were determined by the
method of Bradford (36) using g-globulin as a standard.
Isolation of Purified Sarcolemma and T-tubules by Wheat Germ
Agglutination—To purify the surface membrane preparations, vesicles
from the 23F2 fraction were treated with wheat germ agglutinin (39,
40). Surface membranes were resuspended at a protein concentration of
1 mg/ml in buffer D (50 mM sodium phosphate, 160 mM NaCl, pH 7.4)
and mixed with an equal volume of 1 mg/ml wheat germ lectin (Sigma)
in buffer D. Total volume of this mixture was 600 ml, and after 10 min
incubation in ice, the solution was pelleted in a microcentrifuge for 1.5
min at 15,000 3 g (13,000 rpm). The lectin agglutinated vesicles (W1
fractions) were resuspended in buffer E (20 mM Tris-HCl, 0.250 M
sucrose, pH 7.4) and centrifuged as described above. This procedure was
repeated, and the resuspended pellets were then deagglutinated by
incubation for 20 min at 0 °C in 500 ml of 0.3 M N-acetyl-D-glucosamine
in buffer E. The deagglutinated suspension was centrifuged in a Mi-
crofuge for 1.5 min at 15,000 3 g and the supernatant was pelleted at
150,000 3 g for 60 min (in a TLS-55 Beckman rotor). The pellet was
resuspended in buffer E and frozen in liquid nitrogen. The nonaggluti-
nated vesicles (W2 fractions) were centrifuged for 60 min at 150,000 3
g. The pellet was resuspended in buffer E and stored frozen.
Protocols of Vesicle Immunoisolation—Protein A-purified 1F8 anti-
body was coupled to acrylamide beads (Reacti-gel GF 2000; Pierce) at a
concentration of 1 mg of antibody/ml of resin according to the manufac-
turer’s instructions. Before usage, the beads were saturated with 1%
bovine serum albumin in PBS1 for at least 30 min and washed with
PBS. Intracellular membranes were incubated with beads overnight at
4 °C. The beads were washed five times with PBS, and the adsorbed
material was eluted with electrophoresis sample buffer, incubated for 5
min at 95 °C, cooled, and microcentrifuged. The supernatant fraction
from the vesicle immunoadsorption assay and the immunoadsorbed
extract were subjected to SDS-polyacrylamide gel electrophoresis.
In some assays, antibodies 1F8 (5–7 mg) and 3F8 (3 ml) were incu-
bated overnight at 4 °C with goat anti-mouse IgG- or goat anti-mouse
IgM-coupled to agarose (75 ml of bead volume). Beads were collected by
a 6-s spin in a Microfuge and washed in PBS. Intact membrane prep-
arations (15–25 mg of protein) were incubated with 1F8- or 3F8-Ig-
agarose overnight at 4 °C in the absence of detergents (0.1% bovine
serum albumin, 1 mM EDTA in PBS; final volume, 200 ml). The agarose
beads and vesicles bound to them were collected by a 6-s spin in a
Microfuge. The vesicles that were bound to the immobilized antibody
were washed in PBS. The adsorbed material was eluted with electro-
phoresis sample buffer.
Isolation of Caveolin-rich Membrane Domains—Caveolin-rich mem-
brane domains were prepared from rat skeletal muscle by a minor
modification of an established protocol used for mouse lung (41). Rat
skeletal muscle (400 mg wet weight) was minced with a scissors and
homogenized with 2 ml of 0.1 M Tris buffer, pH 6.5, containing 1%
Triton X-100 and 1 mM phenylmethylsulfonyl fluoride. Homogenization
was carried out with a Polytron (three 5-s bursts). The homogenate was
adjusted to 40% sucrose (w/w) by addition of 0.8 g of sucrose and placed
at the bottom of an ultracentrifuge tube. A 5–30% linear sucrose gra-
dient (in 0.1 M Tris buffer, pH 6.5, lacking Triton X-100) was formed
above the homogenate and centrifuged at 39,000 rpm for 12–16 h.
Gradients were separated into 12 fractions.
Electrophoresis and Immunoblot Analysis—SDS-polyacrylamide gel
electrophoresis was performed on membrane protein following Laemmli
(42). For GLUT1, GLUT4, TGN38, dihydropyridine receptors, Ca21-
ATPase, b1-integrin, tt28, nonreducing 8.5, 10, or 12% polyacrylamide
gels were used. For immunodetection of b-subunit of the insulin recep-
tors and dystrophin, samples were reduced with 100 mM dithiothreitol
and run in 6% gels. Proteins were transferred to Immobilon as previ-
ously reported (43) in buffer consisting of 20% methanol, 200 mM
glycine, 25 mM Tris, pH 8.3. Following transfer, the filters were blocked
with 5% nonfat dry milk, 0.02% sodium azide in PBS for 1 h at 37 °C
and were incubated with antibodies in 1% nonfat dry milk, 0.02%
sodium azide in PBS. Transfer was confirmed by Coomassie Blue stain-
ing of the gel after the electroblot. Detection of the immune complex
with the rabbit polyclonal antibodies was accomplished using 125I-
protein A for 4 h at room temperature. Detection of the immune com-
1 The abbreviation used is: PBS, phosphate-buffered saline.
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plex with monoclonal antibodies was performed using sheep anti-mouse
125I-antibody. Antibody 3F8 was detected using horse radish peroxidase
linked to goat anti-Ig Mmouse secondary antibody and visualized using
an ECL. The autoradiograms were quantified using scanning densitom-
etry. Immunoblots were performed under conditions in which autora-
diographic detection was in the linear response range.
RESULTS
Expression of Caveolin in Rat Skeletal Muscle and Muscle
Cells—In preliminary experiments, we found an abundant ex-
pression of caveolin in membrane preparations of rat skeletal
muscle by Western blot analysis. It has been reported that
adipose tissue contains a larger amount of caveolin protein
than any other tissue (28). In keeping with this, we also found
a very high level of expression of caveolin protein in membrane
preparations from rat white adipose tissue; levels of caveolin
present in rat skeletal muscle accounted for 10% of levels found
in adipose tissue, when data were expressed per g of tissue
(data not shown). The expression of caveolin has been previ-
ously reported in muscle cells (44–46). Based on this, we tried
to determine whether caveolin expression was subjected to
regulation in muscle. Initially, we studied whether myogenesis,
a process that is associated with induction and repression of
many different genes, leads to changes in cellular caveolin
levels. To this end, we used cultured L6E9 cells under a myo-
blast or myotube phenotype. Muscle cell fusion and differenti-
ation is triggered in L6E9 cells after depleting the culture
medium of bovine fetal serum (47). Differentiation of muscle
cells caused the induction of GLUT4 expression (Fig. 1), which
is in keeping with previous observations in L6 cells (48, 49).
Under these conditions, we found a substantial drop in the
cellular levels of caveolin (Fig. 1).
In another set of experiments, we analyzed the muscle con-
tent of caveolin and GLUT4 in two different experimental
conditions known to alter GLUT4 expression in skeletal mus-
cle, i.e. aging and high fat feeding (50–52). To this end, we
compared the expression of caveolin and GLUT4 in skeletal
muscle from 3- and 12-month-old rats. In addition, we also
studied the expression of proteins of 12-month-old rats sub-
jected to a 6-month period of high fat feeding. The level of
GLUT4 decreased 39% in muscle from aged rats compared to
values found in the control group (Fig. 2). Furthermore, levels
of GLUT4 further decreased (46% decrease) in muscle from
aged rats as a result of high fat feeding (Fig. 2). In contrast,
caveolin levels in skeletal muscle increased by 74% in aged rats
compared to young rats (Fig. 2) and a high fat diet further
increased the levels (99% increase compared to aged rats sub-
jected to regular diet) (Fig. 2).
Distribution of Caveolin and GLUT4 in Skeletal Muscle—
The distribution of caveolin and GLUT4 in the muscle fiber
from overnight-fasted rats was next studied by using a previ-
ously described protocol of subcellular fractionation of skeletal
muscle (37). b1-Integrin, a sarcolemmal marker, and dihydro-
pyridine receptor, a T-tubule marker, were mainly detected in
cell surface membrane fractions (Fig. 3A). The cell surface
membranes did not show contamination with sarcoplasmic re-
ticulum vesicles as judged by the absence of sarcoplasmic Ca21-
ATPase (Fig. 3A). In contrast, immunodetectable caveolin,
showing an apparent molecular mass of 22 kDa, and GLUT4
were mainly localized in intracellular membrane fractions
(Fig. 3A).
We have recently reported that agglutination of cell surface
membrane fractions from skeletal muscle leads to the isolation
of three distinct cell surface domains: sarcolemmal fraction 1
(SM1), sarcolemmal fraction 2 (SM2) a T-tubule fraction (37).
In order to determine the localization of caveolin, compara-
tively to GLUT4, in the different cell surface membranes ob-
tained from skeletal muscle, Western blotting of these proteins
was performed on fractions SM1, SM2 and T-tubules. In keep-
ing with previous observations (37), fractions SM1 and SM2
showed a high abundance of b1-integrin, whereas the T-tubule
fraction showed a low abundance of b1-integrin (Fig. 3B). In
keeping with previous observations, GLUT4 was present in all
cell surface fractions, i.e. SM1, SM2, and T-tubules, and
GLUT4 abundance was significantly greater in the T-tubule
than in fractions SM1 or SM2 (Fig. 3B). Similar to the pattern
of GLUT4 distribution, caveolin was found in substantial levels
in all cell surface membranes analyzed (Fig. 3B). Caveolin and
GLUT4 also showed a similar pattern of distribution in the
different intracellular membranes obtained (Fig. 3C). Synapto-
physin, a protein found in peripheral nerve tissue (53) was not
detected in cell surface or in intracellular membranes (data not
shown).
Insulin Redistributes Caveolin in the Muscle Fiber—Recent
studies in 3T3-L1 adipocytes have reported that insulin in-
creases the amount of caveolin found in plasmamembrane (28).
To determine whether insulin also affects the distribution of
caveolin in skeletal muscle, the abundance of GLUT4 and
caveolin in intracellular and cell surface membranes before and
after insulin treatment was next studied (Fig. 4). The in vivo
administration of insulin (30 min after 10 units of insulin/kg of
body weight, intravenously) caused an increased abundance of
FIG. 1. Expression of caveolin and GLUT4 in myoblast and
myotube L6E9 cells. Total membranes were obtained from myoblast
and myotube L6E9 cells. The abundance of caveolin and GLUT4 was
determined by immunoblot analysis by using specific antibodies (see
“Experimental Procedures”). Representative autoradiograms from two
to seven experiments are shown.
FIG. 2. Effect of aging and high fat diet on caveolin and GLUT4
expression in skeletal muscle. Total membrane proteins were puri-
fied from skeletal muscle obtained from 3-month-old rats (Y) and 12-
month-old rats either subjected to regular diet (Ag) or to a high fat diet
(H). The abundance of caveolin and GLUT4 was determined by immu-
noblot analysis by using specific antibodies (see “Experimental Proce-
dures”). Representative autoradiograms from seven to 10 separate ex-
periments are shown.
Distribution and Expression of Caveolin in Muscle Fiber 8135
GLUT4 in cell surface membranes (fraction 23F2, Fig. 4). This
pattern of changes in the distribution of GLUT4 in surface
membranes was specific to the glucose transporter, and no
effect of insulin was detected in the distribution of the surface
markers such as b1-integrin or dihydropyridine receptors (data
not shown). Concomitant to the changes observed in cell sur-
face domains, insulin treatment caused a marked decrease in
the content of GLUT4 in intracellular vesicles derived from
fractions 26F1, 29F1, and 35F1 (Fig. 4). No effect of insulin was
detected in the GLUT4 content of intracellular fractions 26F2,
29F2, or 35F2 (Fig. 4).
The abundance of caveolin was increased in response to
insulin in fractions 23F1 (a cell surface membrane population)
and 26F1 (an intracellular membrane fraction) (levels of caveo-
lin in the insulin-treated group increased by 73 and 72% com-
pared to control values in 23F1 and 26F1, respectively). Under
these conditions, the levels of caveolin were markedly de-
creased in the insulin-treated group in intracellular fractions
29F1 and 35F1 (levels of caveolin decreased in response to
insulin by 95 and 94% in 29F1 and 35F1, respectively) (Fig. 4).
No alterations in the abundance of caveolin were substantiated
in fractions 23F2 (a cell surface membrane fraction) and 26F2,
29F2 and 35F2 (from intracellular origin) (Fig. 4). These data
suggest that insulin redistributes caveolin in a complex man-
ner from some intracellular high density membrane fractions
to intracellular lighter density membranes as well as to the cell
surface.
Caveolin Does Not Colocalize with GLUT4 in Intracellular
Membranes—Based on the similar pattern of distribution
shown by caveolin and GLUT4 in cell surface and in intracel-
lular membranes, we next studied whether these two proteins
colocalized in membranes from skeletal muscle. In a first step,
we isolated caveolin-rich membrane domains by a previously
reported method (41). All of the caveolin was found in light-
density fractions containing Triton-insoluble complexes (Fig.
5). Importantly, proteins characteristic of the plasma mem-
brane such as the a1 subunit of the Na
1-K1-ATPase are ex-
cluded from this low density fraction (data not shown) indicat-
ing that this is a valid procedure for isolation of caveolin-rich
membrane domains. Under these conditions, we detected a low
level of overlapping between the sedimentation pattern of
caveolin-rich membrane domains and GLUT4 (less than 10% of
GLUT4 was found in caveolin-containing fractions) (Fig. 5).
We have identified two distinct pools of intracellular GLUT4-
containing membranes in skeletal muscle based on their dif-
fering insulin response and whereas one pool (membrane frac-
tions 26F2, 29F2, and 35F2) was insulin-insensitive, the other
one (membrane fractions 26F1, 29F1, and 35F1) showed a
marked decrease in GLUT4 content after insulin administra-
tion (Fig. 4). In order to determine whether intracellular caveo-
lin and GLUT4 colocalize in the muscle fiber, vesicle immu-
noisolation assays were performed using antibody 1F8 (against
GLUT4) coupled to acrylic beads, using insulin-sensitive (i.e.
fraction 26F1) or insulin-insensitive (i.e. fraction 26F2) intra-
cellular membrane fractions. Antibody 1F8 immunoadsorbed
nearly 90% and 89% of total GLUT4 from the fractions 26F1
and 26F2, respectively (Fig. 6, A and B). Under these condi-
tions, antibody 1F8 did not immunoadsorb caveolin (Fig. 6, A
and B). We also analyzed whether some degree of colocalization
FIG. 3. Caveolin and GLUT4 are mainly found in intracellular
membranes in skeletal muscle. The abundance of caveolin, GLUT4,
b1-integrin, dihydropyridine receptor and sarcoplasmic Ca
21-ATPase in
cell surface is shown as the percentage of each specific protein found in
cell surface membranes (A) and the results are mean 6 S.E. of four to
six separate experiments. The abundance of caveolin, GLUT4, and
b1-integrin was assayed in surface membrane fractions SM1, SM2, and
TT (B) and in intracellular membranes 26F1, 29F1, 35F1, 26F2, 29F2,
and 35F2 (C) from rat skeletal muscle. The distribution of the caveolin,
GLUT4, b1-integrin, dihydropyridine receptor, and sarcoplasmic Ca
21-
ATPase was determined by immunoblot analysis by using specific
antibodies (see “Experimental Procedures”). Equal amounts of mem-
brane proteins (1 mg for GLU4 and b1-integrin and 4 mg for caveolin)
from the different fractions were laid on gels. Representative autora-
diograms from four to seven experiments are shown in B and C. The
autoradiograms presented in B and C were exposed for different time
periods.
FIG. 4. Insulin redistributes caveolin and GLUT4 inmembrane
fractions from skeletal muscle. The abundance of caveolin and
GLUT4 was assayed in cell surface membrane fractions 23F1 and 23F2
and in intracellular membranes 26F1, 29F1, 35F1, 26F2, 29F2, and
35F2 from control and insulin-stimulated muscles. The distribution of
caveolin and GLUT4 was determined by immunoblot analysis by using
specific antibodies. Equal amounts of membrane proteins (1 mg for
GLUT4 and 4 mg for caveolin) from the different fractions were laid on
gels. Representative autoradiograms, obtained after various times of
exposure, from two to seven separate experiments are shown.
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between caveolin and GLUT4 was detected in insulin-sensitive
GLUT4 pools after in vivo insulin treatment. To this end,
immunoadsorption assays were performed by incubating frac-
tions 26F1 and 29F1 (insulin-sensitive intracellular membrane
fractions) from control and insulin-treated muscles with immo-
bilized antibody 1F8. Antibody 1F8 immunoadsorbed smaller
amounts of GLUT4 in the insulin-treated group than in control
when starting with fraction 26F1 (data not shown). Under
these conditions, caveolin was absent from these vesicle popu-
lation (data not shown). Identical results were obtained with
fraction 29F1 (data not shown).
In other studies, monoclonal antibody 3F8 directed against
SCAMPs was also used in vesicle immunoisolation of insulin-
sensitive and insulin-insensitive GLUT4 pools. Antibody 3F8
immunoadsorbed nearly 38 and 47% of total SCAMP 37 and 18
and 31% of total GLUT4 from fractions 26F1 and 26F2, respec-
tively (data not shown). However, under these conditions, no
caveolin was specifically immunoadsorbed (data not shown).
DISCUSSION
The results of this study demonstrate an abundant expres-
sion of caveolin in muscle and its regulation by myogenesis,
aging and high fat feeding. We have also found that most of
caveolin is distributed intracellularly in skeletal muscle under
basal conditions and that acute insulin administration redis-
tributes caveolin from intracellular high density membranes to
the cell surface and to intracellular lighter density membranes.
These results suggest that caveolin participates in vesicular
traffic in skeletal muscle in an insulin-regulatable manner.
However, intracellular caveolin does not colocalize with
SCAMP proteins, markers of the general cell surface recycling
system (54, 55), or with the GLUT4 glucose transporter iso-
form. In consequence, the vesicular traffic machinery in which
caveolin participates is different than the system associated
with SCAMPs and, at least in skeletal muscle, it is also unre-
lated to the vesicular traffic of GLUT4.
Our data emphasize the importance of understanding the
biological role of caveolin in skeletal muscle. This is based on
two findings, namely that caveolin is abundantly expressed in
skeletal muscle and that its expression is subjected to regula-
tion. That muscle is an abundant source of caveolin is substan-
tiated by the fact that the expression of caveolin in this tissue,
when expressed per gram of tissue, accounts for 10% of values
detected in adipose tissue, which is the most abundant source
of caveolin (28). We have also demonstrated that aging and
high fat feeding, two situations characterized by muscle insulin
resistance (56–58) caused an enhancement of caveolin levels in
skeletal muscle. The biological impact of the up-regulation of
caveolin with aging or high fat feeding is unknown and the
possible implication of caveolin up-regulation and muscle insu-
lin resistance remains undetermined.
We have also observed that the differentiation of L6E9 cells
into myotubes is associated with decreased cellular levels of
caveolin. This does not necessarily mean a decrease in abun-
dance of caveolar organelles during differentiation. In this re-
gard, it has very recently reported a novel homologue of caveo-
lin termed M-caveolin, which is expressed exclusively in
skeletal muscle and heart and its expression is induced upon
muscle differentiation in C2C12 cells (59). The mechanisms by
which caveolin is abundantly expressed in the adult rat skele-
tal muscle but not in cultured myotubes deserves further study.
Caveolin is an integral part of the striated coat of caveolae,
i.e. non-clathrin-coated invaginations of the plasmamembrane.
Caveolin seems to internalize from caveolae to intracellular
compartments in response to okadaic acid (60). Cholesterol
oxidation also causes the movement of caveolin from caveolae
to the Golgi apparatus (61) in the absence of changes in the
number or morphology of caveolae. This together with the
observation that caveolin is an integral component of trans-
Golgi network-derived transport vesicles (62) supports the view
that caveolin is a component of the molecular machinery of
vesicular transport. In this regard, we have found that in
skeletal muscle, caveolin is mainly distributed intracellularly.
Under basal conditions, 77% of all caveolin found in muscle
membranes was detected intracellularly. This distribution pat-
tern is similar to the distribution of SCAMP proteins (63) and
to GLUT4 glucose transporter in skeletal muscle. The distri-
bution of caveolin in intracellular membranes from rat skeletal
muscle suggests a functional role in vesicular transport.
FIG. 5. Subcellular localization of GLUT4 and caveolin in rat
skeletal muscle. Rat skeletal muscle was homogenized in buffer con-
taining 1% Triton X-100, brought to 40% sucrose and overlaid with a
linear 5–30% sucrose gradient lacking detergent. After centrifugation
for 12–16 h at 39,000 rpm, 12 fractions were harvested. An equal
volume of each fraction was analyzed by SDS-polyacrylamide gel elec-
trophoresis and Western blotting for the distribution of caveolin and
GLUT4.
FIG. 6. Absence of caveolin in intracellular insulin-sensitive
and insulin-insensitive GLUT4 pools. Membrane vesicles 26F1 (in-
sulin-sensitive GLUT4 pool) (A) and membrane vesicles 26F2 (insulin-
insensitive GLUT4 pool) (B) obtained from from nonstimulated skeletal
muscle were incubated with (1) or without (2) antibody 1F8. After the
incubation, the adsorbed (P) and nonadsorbed (S) fractions were elec-
trophoresed and immunoblotted to determine the abundance of caveolin
and GLUT4. Autoradiographs were subjected to scanning densitome-
try. Representative autoradiograms, obtained after various times of
exposure, are shown.
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Under our experimental conditions, we found that in vivo
insulin administration caused a marked redistribution of
caveolin in skeletal muscle. Thus, caveolin moved from high
density intracellular membranes to the cell surface and to
intracellular membranes of lower density. This is in keeping
with previous observations in 3T3-L1 adipocytes indicating
that insulin increased the amount of caveolin present in the
plasma membrane and a decrease in the amount of caveolin
associated with low density microsomes (28). This pattern of
insulin-induced redistribution of caveolin is fairly similar to
the effect of insulin on the distribution of SCAMPs in skeletal
muscle (63). However, the redistribution of caveolin was mark-
edly different than the insulin-induced translocation of
GLUT4. The biological role of the insulin-triggered redistribu-
tion of caveolin in skeletal muscle deserves further study.
It is important to determine whether caveolin and GLUT4
interact in the muscle fiber. This aspect has been studied in this
report in a number of ways. Caveolin-rich membrane domains
were isolated from rat skeletal muscle which revealed that less
than 10% of total GLUT4 overlapped with caveolin-containing
fractions. Additionally, the colocalization of GLUT4 and caveolin
in intracellular membranes was done by vesicle immunoadsorp-
tion analysis. In these studies we used two distinct intracellular
GLUT4 pools previously obtained from rat skeletal muscle (63):
one intracellular GLUT4 pool that is insulin-sensitive since in-
sulin administration causes a large depletion of this pool, and a
second pool that is insulin-insensitive in terms of GLUT4 con-
tent. Vesicle immunoisolation assays clearly indicated that
caveolin was absent from these distinct intracellular GLUT4-
containing membranes obtained from muscle under basal or in-
sulin-stimulated conditions. This allows us to conclude that
caveolin is not an intermediate in intracellular trafficking of
GLUT4 in skeletal muscle. If the overlapping found between
GLUT4 and caveolin-rich membrane domains was interpreted as
real colocalization between GLUT4 and caveolin, these data to-
gether with results obtained from vesicle immunoisolation anal-
ysis would be consistent with the idea that caveolin-rich mem-
brane domains act as transient intermediates in GLUT4
endocytosis and/or exocytosis in muscle. This hypothesis requires
extensive experimental work.
In any case, our studies indicate that caveolin is not an
intermediate in intracellular trafficking of GLUT4 in skeletal
muscle, as found in isolated rat adipocytes (29) and in contrast
to what has been suggested in 3T3-L1 adipocytes (28). The
reason for this discrepancy is at present unknown but it should
be mentioned that 3T3-L1 adipocytes also shows marked dif-
ferences compared with isolated rat adipocytes in the traffick-
ing of GLUT1 and GLUT4, and whereas GLUT1 and GLUT4
largely colocalize in 3T3-L1 they are completely seggregated in
rat adipocytes (64–66).
We also searched for colocalization of caveolin with SCAMPs
proteins. SCAMPs are expressed in rat skeletal muscle where
they show an intracellular distribution (63). Insulin has been
found to alter the cellular distribution of SCAMPs in adipocytes
and in skeletal muscle and a variable extent of colocalization
has been reported between intracellular SCAMPs and GLUT4
in adipocytes (18, 19, 63). To determine whether SCAMPs and
caveolin colocalize in skeletal muscle membranes, intracellular
SCAMP-containing vesicles were immunoisolated with immo-
bilized antibody 3F8. Under conditions, in which we immu-
noisolated near 40–50% of SCAMPs, caveolin was absent from
the immunoprecipitates. In consequence, we conclude that
there is a seggregation of SCAMPs and caveolin in intracellular
membranes from rat skeletal muscle. In summary, based on
the pattern of cellular distribution caused by insulin and on the
lack of colocalization between caveolin and GLUT4 or SCAMPs,
we propose the activity of, at least, three separate insulin-
regulated mechanisms for vesicular transport in skeletal mus-
cle. One system is characterized by the presence of caveolin, the
second is characterized by the presence of SCAMPs and the
third is involved in the recycling of GLUT4 glucose carriers.
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